Author

R. M. Meganck

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Assay:CITE-seq· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. M. DeSilva· 2 shared L. J. White· 2 shared L. V. Tse· 2 shared R. Baric· 2 shared S. Dong· 2 shared D. J. Thiono· 1 shared D. Zhu· 1 shared L. E. Adams· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. M. DeSilva

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintMar 22, 2023

Evolution of a Functionally Intact but Antigenically Distinct DENV Fusion Loop

R. M. Meganck, D. Zhu, S. Dong…·L. V. Tse

This study engineers DENV variants with mutated fusion loops that evade neutralizing antibodies but retain sensitivity to cross-reactive antibodies, offering tools for vaccine development.

DOI 10.1101/2023.03.22.533803

non-human primateexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintApr 6, 2021

Genetically Engineered DENV Produces Antigenically Distinct Mature Particles

L. V. Tse, R. M. Meganck, S. Dong…·R. Baric

This study genetically engineers DENV to produce antigenically distinct mature particles, offering new tools for vaccine development and maturation studies.

DOI 10.1101/2021.04.06.438747

humanmouse

𝕏 PostBluesky